Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohort

被引：0
|
作者：
Vaz-Goncalves, Larissa [1 ]
Marquart-Wilson, Louise [1 ]
Protani, Melinda M. [1 ]
Saunus, Jodi M. [2 ]
Moore, Julie [3 ]
Morris, Michelle J. [4 ]
Reeves, Marina M. [1 ]
机构：
[1] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia
[2] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia
[3] Metro South Hosp & Hlth Serv, Princess Alexandra Hosp, Canc Alliance Queensland, Brisbane, Qld, Australia
[4] Univ Sunshine Coast, Sunshine Coast, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [31] NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    He, Xiangming
    Gu, Jinping
    Zou, Dehong
    Yang, Hongjian
    Zhang, Yongfang
    Ding, Yuqing
    Teng, Lisong
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [32] Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort
    Qiu, Yu
    Chen, Yan
    Shen, Haoyang
    Yan, Shuixin
    Li, Jiadi
    Wu, Weizhu
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [33] Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer
    Mohamed Omar
    Pier Vitale Nuzzo
    Francesco Ravera
    Sara Bleve
    Giuseppe Nicolò Fanelli
    Claudio Zanettini
    Itzel Valencia
    Luigi Marchionni
    Journal of Translational Medicine, 21
  • [34] Gene signature-based prediction of triple-negative breast cancer patient response to Neoadjuvant chemotherapy
    Zhao, Yanding
    Schaafsma, Evelien
    Cheng, Chao
    CANCER MEDICINE, 2020, 9 (17): : 6281 - 6295
  • [35] Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer
    Omar, Mohamed
    Nuzzo, Pier Vitale
    Ravera, Francesco
    Bleve, Sara
    Fanelli, Giuseppe Nicolo
    Zanettini, Claudio
    Valencia, Itzel
    Marchionni, Luigi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [36] Poor histological subtype and response to neoadjuvant treatment in triple-negative breast cancer
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (03): : 1665 - 1665
  • [37] Differential Response of Triple-Negative Breast Cancer to a Docetaxel and Carboplatin-Based Neoadjuvant Treatment
    Chang, Helena R.
    Glaspy, John
    Allison, Mary Ann
    Kass, Frederic C.
    Elashoff, Robert
    Chung, Debra U.
    Gornbein, Jeffrey
    CANCER, 2010, 116 (18) : 4227 - 4237
  • [38] A brief review of treatment options for neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Tiwari, Akash
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (02) : 247 - 249
  • [39] Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
    Zheng, Yi-Zi
    Ying, Jia-Qi
    Wu, Ting-Ting
    Su, Yong-Hui
    Wang, Ou-Chen
    BREAST, 2025, 79
  • [40] De-escalating treatment with neoadjuvant chemotherapy in early triple-negative breast cancer
    Murillo, Serafin Morales
    Cudos, Ariadna Gasol
    Der-Abrain, Noemi Tuset
    CANCER RESEARCH, 2024, 84 (09)
12345